1887

Abstract

The objective of this study was to determine the antibiotic resistance amongst beta-haemolytic streptococci (BHS) from North India. A total of 155 BHS isolates, comprising group A streptococci (GAS) (102), group C streptococci (GCS) (25) and group G streptococci (GGS) (28), collected from patients with pharyngitis, rheumatic fever, skin disease and invasive disease were analysed for their antimicrobial susceptibility to 20 antibiotics using the Kirby–Bauer disc diffusion method. The MICs of penicillin, tetracycline, clarithromycin, azithromycin and erythromycin were also determined using the HiComb test, following the Clinical and Laboratory Standards Institute guidelines. The results showed that 37.4 % of BHS isolates were susceptible to all antibiotics and 19.4 % were highly resistant to tetracycline; however, only 2.6–5.2 % were resistant to macrolides. The tetracycline resistance (<0.05) of BHS was found to be statistically significant. GAS isolates from different sources of infection also showed statistically significant antibiotic resistance to azithromycin ( = 0.029). Multi-drug resistance was found irrespective of streptococcal types. No association between GAS types and drug resistance was seen. MIC determination showed all isolates to be susceptible to the five antibiotics tested, except for two GAS and one GGS isolates that were resistant to clarithromycin, and one GAS skin isolate that was resistant to tetracycline. This study suggests that the variation in antibiotic resistance amongst BHS isolates from North India is independent of the isolation source and type distribution, hence emphasizing the need for a longitudinal surveillance in different regions of India.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.046672-0
2013-03-01
2024-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/3/386.html?itemId=/content/journal/jmm/10.1099/jmm.0.046672-0&mimeType=html&fmt=ahah

References

  1. Aggarwal P., Ichhpujani R. L., Rai Chowdhuri A. N. 1984; Antibiotic sensitivity of beta-haemolytic streptococci – a four year rural and urban survey report. J Commun Dis 16:131–135[PubMed]
    [Google Scholar]
  2. Bharathi R. S., Sharma V., Sood R., Chakladar A., Singh P., Raman D. K. 2009; Management of necrotizing myositis in a field hospital: a case report. Scand J Trauma Resusc Emerg Med 17:20 [View Article][PubMed]
    [Google Scholar]
  3. Bisno A. L., Kaplan E. L. 2002; Appropriate use of antibiotics: pharyngitis. Ann Intern Med 136:489–490[PubMed] [CrossRef]
    [Google Scholar]
  4. Brahmadathan K. N., Anitha P., Gladstone P. 2005; Increasing erythromycin resistance among group A streptococci causing tonsillitis in a tertiary care hospital in southern India. Clin Microbiol Infect 11:335–337 [View Article][PubMed]
    [Google Scholar]
  5. Capoor M. R., Nair D., Deb M., Batra K., Aggarwal P. 2006; Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India. Jpn J Infect Dis 59:334–336[PubMed]
    [Google Scholar]
  6. CLSI 2012; Performance Standards for Antimicrobial Disk Susceptibility Testing; 22nd Information Supplement, M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute;
  7. Dhakal R., Sujatha S., Parija S. C., Bhat B. V. 2010; Asymptomatic colonization of upper respiratory tract by potential bacterial pathogens. Indian J Pediatr 77:775–778 [View Article][PubMed]
    [Google Scholar]
  8. Erdem G., Ford J., Johnson D., Abe L., Yamaga K., Kaplan E. 2005; Erythromycin-resistant group A streptococcal isolates collected between 2000 and 2005 in Oahu, Hawaii, and their emm types. J Clin Microbiol 43:2497–2499 [View Article][PubMed]
    [Google Scholar]
  9. Hsueh P. R., Shyr J. M., Wu J. J. 2005; Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan. Clin Infect Dis 40:903–905 [View Article][PubMed]
    [Google Scholar]
  10. Hull Vance S., Tucci M., Benghuzzi H. 2011; Evaluation of the antimicrobial efficacy of green tea extract (egcg) against streptococcus pyogenes in vitro – biomed 2011. Biomed Sci Instrum 47:177–182[PubMed]
    [Google Scholar]
  11. Inoue M., Farrell D. J., Kaneko K., Akizawa K., Fujita S., Kaku M., Igari J., Yamaguchi K., Yamanaka K. other authors 2008; Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–5 (1999–2004). Microb Drug Resist 14:109–117 [View Article][PubMed]
    [Google Scholar]
  12. Jain A., Shukla V. K., Tiwari V., Kumar R. 2008; Antibiotic resistance pattern of group-A beta-hemolytic streptococci isolated from North Indian children. Indian J Med Sci 62:392–396 [View Article][PubMed]
    [Google Scholar]
  13. Kataja J., Huovinen P., Muotiala A., Vuopio-Varkila J., Efstratiou A., Hallas G., Seppälä H. Finnish Study Group for Antimicrobial Resistance 1998; Clonal spread of group A streptococcus with the new type of erythromycin resistance. J Infect Dis 177:786–789 [View Article][PubMed]
    [Google Scholar]
  14. Kittang B. R., Bruun T., Langeland N., Mylvaganam H., Glambek M., Skrede S. 2011; Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes. Clin Microbiol Infect 17:358–364 [View Article][PubMed]
    [Google Scholar]
  15. Koh E. H., Kim S., Lee N. Y. 2008; Decrease of erythromycin resistance in group A streptococci by change of emm distribution. Jpn J Infect Dis 61:261–263[PubMed]
    [Google Scholar]
  16. Lindbaek M., Høiby E. A., Lermark G., Steinsholt I. M., Hjortdahl P. 2005; Clinical symptoms and signs in sore throat patients with large colony variant beta-haemolytic streptococci groups C or G versus group A. Br J Gen Pract 55:615–619[PubMed]
    [Google Scholar]
  17. Lloyd C. A., Jacob S. E., Menon T. 2007; Antibiotic resistant beta-hemolytic streptococci. Indian J Pediatr 74:1077–1080 [View Article][PubMed]
    [Google Scholar]
  18. Macris M. H., Hartman N., Murray B., Klein R. F., Roberts R. B., Kaplan E. L., Horn D., Zabriskie J. B. 1998; Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatr Infect Dis J 17:377–381 [View Article][PubMed]
    [Google Scholar]
  19. Mathur P., Kapil A., Das B., Dhawan B., Dwivedi S. N. 2002; Invasive beta-haemolytic streptococcal infections in a tertiary care hospital in northern India. J Med Microbiol 51:791–792[PubMed]
    [Google Scholar]
  20. Metzgar D., McDonough E. A., Hansen C. J., Blaesing C. R., Baynes D., Hawksworth A. W., Blair P. J., Faix D. J., Russell K. L. 2010; Local changes in rates of group A streptococcus disease and antibiotic resistance are associated with geographically widespread strain turnover events. Virulence 1:247–253 [View Article][PubMed]
    [Google Scholar]
  21. Navaneeth B. V., Ray N., Chawda S., Selvarani P., Bhaskar M., Suganthi N. 2001; Prevalence of beta hemolytic streptococci carrier rate among schoolchildren in Salem. Indian J Pediatr 68:985–986 [View Article][PubMed]
    [Google Scholar]
  22. Norton R., Smith H.V., Wood N., Siegbrecht E., Ross A., Ketheesan N. 2004; Invasive group A streptococcal disease in North Queensland (1996–2001). Indian J Med Res 119 S:148–151
    [Google Scholar]
  23. Oliver M. A., García-Rey C., Bosch R., Albertí S. 2007; Evaluation of the ability of erythromycin-resistant and -susceptible pharyngeal group A streptococcus isolates from Spain to enter and persist in human keratinocytes. J Med Microbiol 56:1485–1489 [View Article][PubMed]
    [Google Scholar]
  24. Pfaller M.A., Jones R.N. Microbiology Resource Committee, College of American Pathologists 2006; Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists microbiology surveys program (2001–2003). Arch Pathol Lab Med 130:767–778
    [Google Scholar]
  25. Ray D., Sinha S., Saha S., Karmakar S., Dutta R. N., Bhattacharya S., Pal N. K., Bhattacharya B. 2010; A preliminary sentinel surveillance report on antibiotic resistance trend of Streptococcus pyogenes in Kolkata region, India. Am J Med Sci 3:146–151
    [Google Scholar]
  26. Rijal K. R., Dhakal N., Shah R. C., Timilsina S., Mahato P., Thapa S., Ghimire P. 2009; Antibiotic susceptibility of group A streptococcus isolated from throat swab culture of school children in Pokhara, Nepal. Nepal Med Coll J 11:238–240[PubMed]
    [Google Scholar]
  27. Rowe R. A., Stephenson R. M., East D. L., Wright S. 2009; Mechanisms of resistance for Streptococcus pyogenes in northern Utah. Clin Lab Sci 22:39–44[PubMed]
    [Google Scholar]
  28. Savini V., Catavitello C., Talia M., Manna A., Pompetti F., Di Bonaventura G., Di Giuseppe N., Febbo F., Balbinot A. other authors 2008; β-lactam failure in treatment of two group G Streptococcus dysgalactiae subsp. equisimilis pharyngitis patients. J Clin Microbiol 46:814–816 [View Article][PubMed]
    [Google Scholar]
  29. Smeesters P. R., Cadar S., Drèze P. A., Campos D., Van Melderen L. 2010; Polyclonal dissemination of tetracycline resistance among Streptococcus pyogenes paediatric isolates from Brazil. J Infect Dev Ctries 4:704–711 [View Article][PubMed]
    [Google Scholar]
  30. Traub W. H., Leonhard B. 1997; Comparative susceptibility of clinical group A, B, C, F, and G β-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 43:10–20 [View Article][PubMed]
    [Google Scholar]
  31. Zaoutis T., Schneider B., Steele Moore L., Klein J. D. 1999; Antibiotic susceptibilities of group C and group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes. J Clin Microbiol 37:3380–3383[PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.046672-0
Loading
/content/journal/jmm/10.1099/jmm.0.046672-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error